A detailed history of Fmr LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,470,057 shares of ORIC stock, worth $33.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,470,057
Previous 2,480,420 0.42%
Holding current value
$33.2 Million
Previous $13.8 Million 81.15%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$4.26 - $10.55 $44,146 - $109,329
-10,363 Reduced 0.42%
2,470,057 $25.1 Million
Q1 2025

May 12, 2025

BUY
$5.58 - $12.54 $70,369 - $158,141
12,611 Added 0.51%
2,480,420 $13.8 Million
Q4 2024

Feb 13, 2025

SELL
$7.68 - $10.3 $14.7 Million - $19.7 Million
-1,911,010 Reduced 43.64%
2,467,809 $19.9 Million
Q3 2024

Nov 13, 2024

SELL
$7.52 - $11.9 $4.07 Million - $6.44 Million
-541,541 Reduced 11.01%
4,378,819 $44.9 Million
Q2 2024

Aug 13, 2024

SELL
$6.63 - $12.93 $691,111 - $1.35 Million
-104,240 Reduced 2.07%
4,920,360 $34.8 Million
Q1 2024

May 13, 2024

SELL
$8.04 - $16.03 $15.9 Million - $31.7 Million
-1,977,508 Reduced 28.24%
5,024,600 $69.1 Million
Q4 2023

Feb 13, 2024

BUY
$5.41 - $9.43 $20.9 Million - $36.5 Million
3,869,914 Added 123.55%
7,002,108 $64.4 Million
Q3 2023

Nov 13, 2023

SELL
$6.05 - $9.28 $3.63 Million - $5.57 Million
-600,054 Reduced 16.08%
3,132,194 $18.9 Million
Q2 2023

Aug 11, 2023

SELL
$4.95 - $8.4 $1.36 Million - $2.31 Million
-274,851 Reduced 6.86%
3,732,248 $29 Million
Q1 2023

May 11, 2023

SELL
$4.26 - $6.75 $40,508 - $64,185
-9,509 Reduced 0.24%
4,007,099 $22.8 Million
Q4 2022

Feb 13, 2023

SELL
$2.41 - $5.89 $799,599 - $1.95 Million
-331,784 Reduced 7.63%
4,016,608 $23.7 Million
Q3 2022

Nov 10, 2022

SELL
$3.15 - $5.24 $21,388 - $35,579
-6,790 Reduced 0.16%
4,348,392 $13.9 Million
Q2 2022

Aug 12, 2022

SELL
$2.7 - $7.07 $170,723 - $447,043
-63,231 Reduced 1.43%
4,355,182 $19.5 Million
Q1 2022

May 13, 2022

SELL
$4.54 - $16.1 $6.76 Million - $24 Million
-1,488,866 Reduced 25.2%
4,418,413 $23.6 Million
Q4 2021

Feb 14, 2022

BUY
$12.01 - $20.3 $115,620 - $195,428
9,627 Added 0.16%
5,907,279 $86.8 Million
Q3 2021

Nov 15, 2021

BUY
$15.9 - $25.22 $6.25 Million - $9.92 Million
393,280 Added 7.14%
5,897,652 $123 Million
Q2 2021

Aug 13, 2021

BUY
$17.37 - $25.34 $95.6 Million - $139 Million
5,504,372 New
5,504,372 $97.4 Million

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $532M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.